FDA Clearance Tracker · K262597
Access BNP II
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Oct 20, 2026
Substantially Equivalent
Time to decision
85 days
Received Jul 27, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K262597
- Device name
- Access BNP II
- Applicant
- Beckman Coulter, Inc.
- Applicant location
- Chaska, MN
- Received
- Jul 27, 2026
- Decided
- Oct 20, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Natriuretic Peptide (NBC)
- Device class
- Class II
- Regulation
- 21 CFR 862.1117
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NBC. The earliest in FDA's data is DEN000010, decided Nov 20, 2000.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K262597
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Beckman Coulter, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Access MeMed BV510(k)
K261109 · Decided Oct 19, 2026 · 199 days after receipt
Device type: Immunoassay For Host Biomarkers Of Infection (QPS) · Laboratory Medicine & Pathology
- Access NT-proBNP510(k)
K262109 · Decided Sep 21, 2026 · 90 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
- Access BNP II510(k)
K252169 · Decided Mar 24, 2026 · 257 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.